Summary of clinical results

DUCRAY
KELUAL DS GEL NETTOYANT ANTI-SQUAME

Clinical safety and efficacy study of KELUAL DS Anti-Squamous Cleansing Gel in subjects with seborrheic dermatitis

Tolerance and efficacy study under dermatological control of KELUAL DS Anti-Squamous Cleansing Gel for face and body in teenagers and adults with mild to moderate seborrheic dermatitis of the face.

Population

30 subjects included with :

  • At least 25% males. 
  • 10 adolescents (12 to 17 years)
  • 20 adults (18 to 65 years)

with mild to moderate seborrheic dermatitis of the face

  • Erythema ≥ 1
  • Pruritus ≥ 1
  • Desquamation ≥ 1

Application of KELUAL DS Anti-Squamous Cleansing Gel

1 single application per day 

Evaluation criteria

  • Clinical score by investigator: desquamation, erythema (scale from 0 to 4)
  • Subject rating: average pruritus (analog scale from 0 to 10)
  • Cutaneous and ocular tolerance

Results

Highly significant reduction in clinical signs after 7 days of treatment: desquamation, pruritus and erythema 

Intra-group analysis**: p<0.001

Evolution of the clinical score after 21 days of treatment 

Seborrheic dermatitis

image 1

** p<0.001 vs Baseline

Conclusion

After 7 days of treatment, KELUAL DS Anti-Squamous Cleansing Gel improves clinical symptoms such as desquamation, erythema and pruritus.

Very good cutaneous and ocular tolerance.

More summaries of clinical results